| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1757 | |
| Phytochemical name or plant extracts | Rheum emodi extract | |
| PMID | 21875266 | |
| Literature evidence | The ability of the extracts to induce apoptosis in MDA-MB-435S (human breast carcinoma), Hep3B (human hepatocellular carcinoma) and PC-3 (human prostate cancer) cell lines were tested by ELISA to detect cellular DNA fragmentation. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Extract | |
| Source of phytochemicals or plant Extracts | Rheum emodi | |
| Geographical availability | Nepal, Pakistan, Tibet, West Himalaya | |
| Plant parts | Rhizome | |
| Other cancers | Breast cancer, Liver cancer, Prostate cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | The strategy employed in this study, to induce apoptosis in the tumor cells, could be a potential target of therapeutic intervention of cancers. | |
| Cell line/ mice model | MDA-MB-435S, Hep3B, PC-3 | |
| Additional information | he study concludes that R. emodi possess anticancer metabolites that can be isolated and used as precursors in development of anticancer drugs. | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:696733-1 | |
| Safety | NA |